CN103638136A - 虫草芪参胶囊 - Google Patents
虫草芪参胶囊 Download PDFInfo
- Publication number
- CN103638136A CN103638136A CN201310710323.5A CN201310710323A CN103638136A CN 103638136 A CN103638136 A CN 103638136A CN 201310710323 A CN201310710323 A CN 201310710323A CN 103638136 A CN103638136 A CN 103638136A
- Authority
- CN
- China
- Prior art keywords
- cordyceps
- radix
- filtrate
- decoct
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 25
- 241000208340 Araliaceae Species 0.000 title claims abstract description 23
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 23
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 23
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 title claims abstract description 23
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 23
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 title claims abstract description 23
- 235000021286 stilbenes Nutrition 0.000 title claims abstract description 23
- 241000233866 Fungi Species 0.000 title abstract 5
- 240000001307 Myosotis scorpioides Species 0.000 title abstract 5
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 206010018367 Glomerulonephritis chronic Diseases 0.000 claims abstract description 14
- 241000190633 Cordyceps Species 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 239000003814 drug Substances 0.000 claims description 23
- 239000000706 filtrate Substances 0.000 claims description 20
- 210000000582 semen Anatomy 0.000 claims description 20
- 241000628997 Flos Species 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 12
- 239000009636 Huang Qi Substances 0.000 claims description 11
- 241001649190 Campsis Species 0.000 claims description 6
- 244000268590 Euryale ferox Species 0.000 claims description 6
- 235000006487 Euryale ferox Nutrition 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 240000008669 Hedera helix Species 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 14
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 25
- 210000000952 spleen Anatomy 0.000 description 17
- 206010030113 Oedema Diseases 0.000 description 15
- 210000002700 urine Anatomy 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 208000017169 kidney disease Diseases 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 6
- 230000003907 kidney function Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 5
- 206010001580 Albuminuria Diseases 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000004064 recycling Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 208000037157 Azotemia Diseases 0.000 description 3
- 206010030302 Oliguria Diseases 0.000 description 3
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 229940109239 creatinine Drugs 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 208000006750 hematuria Diseases 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 208000009852 uremia Diseases 0.000 description 3
- 206010018092 Generalised oedema Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000024783 anasarca Diseases 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000001794 hormone therapy Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000004538 Bacteriuria Diseases 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 208000022461 Glomerular disease Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010050791 Leukocyturia Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000008718 Pyuria Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038419 Renal colic Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000007937 eating Effects 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 231100000852 glomerular disease Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000009592 kidney function test Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229940096335 prednisone 1 mg Drugs 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000008327 renal blood flow Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
组别 | 显效 | 有效 | 无效 | 总有效率 |
对照组 | 11 | 19 | 10 | 75% |
实施例1组 | 18 | 16 | 6 | 85% |
实施例2组 | 28 | 11 | 1 | 97.5% |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310710323.5A CN103638136B (zh) | 2013-12-22 | 2013-12-22 | 虫草芪参胶囊 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310710323.5A CN103638136B (zh) | 2013-12-22 | 2013-12-22 | 虫草芪参胶囊 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103638136A true CN103638136A (zh) | 2014-03-19 |
CN103638136B CN103638136B (zh) | 2015-09-16 |
Family
ID=50243508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310710323.5A Active CN103638136B (zh) | 2013-12-22 | 2013-12-22 | 虫草芪参胶囊 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103638136B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104623387A (zh) * | 2015-03-11 | 2015-05-20 | 贾学亮 | 一种用于治疗慢性肾炎的药物组合物 |
CN106491747A (zh) * | 2016-12-27 | 2017-03-15 | 翔宇药业股份有限公司 | 虫草芪参胶囊的制备及质量标准检测方法 |
CN106728079A (zh) * | 2016-12-27 | 2017-05-31 | 翔宇药业股份有限公司 | 虫草芪参胶囊制剂的生产方法 |
CN106728080A (zh) * | 2016-12-27 | 2017-05-31 | 翔宇药业股份有限公司 | 一种治疗慢性肾炎的复方药物的制备工艺 |
CN108126026A (zh) * | 2016-12-01 | 2018-06-08 | 林凡友 | 虫草芪参胶囊的制备方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109511758A (zh) * | 2018-04-17 | 2019-03-26 | 姚元义 | 葛参芪茶 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1091968A (zh) * | 1993-03-06 | 1994-09-14 | 管益君 | 一种药品及其制备方法 |
-
2013
- 2013-12-22 CN CN201310710323.5A patent/CN103638136B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1091968A (zh) * | 1993-03-06 | 1994-09-14 | 管益君 | 一种药品及其制备方法 |
Non-Patent Citations (1)
Title |
---|
徐锡兰等: "虫草芪参胶囊治疗慢性肾炎60例临床研究", 《山东中医药大学学报》, vol. 29, no. 06, 30 November 2005 (2005-11-30), pages 446 - 448 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104623387A (zh) * | 2015-03-11 | 2015-05-20 | 贾学亮 | 一种用于治疗慢性肾炎的药物组合物 |
CN108126026A (zh) * | 2016-12-01 | 2018-06-08 | 林凡友 | 虫草芪参胶囊的制备方法 |
CN108126026B (zh) * | 2016-12-01 | 2021-01-08 | 翔宇药业股份有限公司 | 虫草芪参胶囊的制备方法 |
CN106491747A (zh) * | 2016-12-27 | 2017-03-15 | 翔宇药业股份有限公司 | 虫草芪参胶囊的制备及质量标准检测方法 |
CN106728079A (zh) * | 2016-12-27 | 2017-05-31 | 翔宇药业股份有限公司 | 虫草芪参胶囊制剂的生产方法 |
CN106728080A (zh) * | 2016-12-27 | 2017-05-31 | 翔宇药业股份有限公司 | 一种治疗慢性肾炎的复方药物的制备工艺 |
CN106728080B (zh) * | 2016-12-27 | 2020-02-21 | 翔宇药业股份有限公司 | 一种治疗慢性肾炎的复方药物的制备工艺 |
CN106728079B (zh) * | 2016-12-27 | 2020-02-21 | 翔宇药业股份有限公司 | 虫草芪参胶囊制剂的生产方法 |
CN106491747B (zh) * | 2016-12-27 | 2020-03-24 | 翔宇药业股份有限公司 | 虫草芪参胶囊的制备及质量标准检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103638136B (zh) | 2015-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103536638B (zh) | 一种治疗胃肠功能紊乱的药物及其制备方法 | |
CN103638136B (zh) | 虫草芪参胶囊 | |
CN101934025B (zh) | 一种用于清热解毒的中药 | |
CN1927379A (zh) | 治疗儿童肺系疾病的中药制剂 | |
CN104225441A (zh) | 一种治疗胃病的中药组合物及其颗粒剂和胶囊剂的制备方法 | |
CN101332282B (zh) | 一种治疗肾虚阴冷所致妇科疾病的中药组合物及制备方法 | |
CN103432485B (zh) | 一种治疗尿结石的中药制剂及制备方法 | |
CN103638135A (zh) | 清浊益肾胶囊 | |
CN103071018A (zh) | 治疗早期习惯性流产的中药制剂 | |
CN103611027B (zh) | 一种临床预防、护理和治疗滴虫性***炎的药物组合物 | |
CN102935214B (zh) | 一种治疗***的中药组合物 | |
CN105194482A (zh) | 一种用于慢性肾病的药物制剂 | |
CN105233117A (zh) | 用于治疗肾病的药物组合物及其制备方法 | |
CN102125671A (zh) | 一种治疗肾虚阴冷所致妇科疾病的中药组合物及制备方法 | |
CN104623387A (zh) | 一种用于治疗慢性肾炎的药物组合物 | |
CN101024054B (zh) | 一种内服治疗腺性膀胱炎的中药组合物 | |
CN104800729A (zh) | 益肾复元消白汤 | |
CN104001070A (zh) | 一种治疗便秘的中药组合物 | |
CN103520638B (zh) | 一种治疗***肥大症的中药复方组合物及其制备方法及其应用 | |
CN103191345B (zh) | 一种慢性消化性溃疡和食管炎综合征术后用药 | |
CN101612275B (zh) | 治疗肾病综合症的中药及其制备方法 | |
CN105194165A (zh) | 一种用于泌尿***感染的中药及制备方法 | |
CN105288344A (zh) | 一种用于治疗肝胆结石的中药组合物及其应用 | |
CN104162104A (zh) | 一种用于治疗慢性萎缩性胃炎的药物 | |
CN104013871A (zh) | 一种治疗慢性肾炎的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANDONG XIANGYU HEALTH PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LIN FANYOU Effective date: 20140710 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140710 Address after: 276023 No. 30, Hangzhou Road, Linyi economic and Technological Development Zone, Linyi, Shandong Applicant after: Shandong Xiangyu Health Pharmaceutical Co., Ltd. Address before: 276023 Beijing road Shandong Linyi Province, Linyi City Economic Development Zone No. 30 Shandong Xiangyu Health Pharmaceutical Co. Ltd. Applicant before: Lin Fanyou |
|
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 276023 No. 30, Hangzhou Road, Linyi economic and Technological Development Zone, Linyi, Shandong Applicant after: Xiang Yu Pharmaceutical limited company Address before: 276023 No. 30, Hangzhou Road, Linyi economic and Technological Development Zone, Linyi, Shandong Applicant before: Shandong Xiangyu Health Pharmaceutical Co., Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: SHANDONG XIANGYU HEALTH PHARMACEUTICAL CO., LTD. TO: XIANGYU PHARMACEUTICAL CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |